| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da54f7ebbd2d9d8a82f92aca4d1b4e48 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F7-1804
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C57-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C57-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C405-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-4015 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-593
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-533 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F7-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C405-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C57-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-557
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C57-13 |
| filingDate |
1982-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1986-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a079d6172a1fb1d237e73b48c4d11e63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14dc9915b4ff2251417f2097a6311db6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a7f309e46f1dd9fe6033fc7eb6f5675 |
| publicationDate |
1986-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-1205469-A |
| titleOfInvention |
9-oxo-13,18-prostadienoic acid derivatives and process for their preparation |
| abstract |
Abstract 9-oxo-13,18-prostadienoic acid derivatives and process for their preparation A (13E)-(8R,11R,12R)-11-15-dihydroxy-9-oxo-13,18-prostadienoic acid which is substituted at the 16-position by one or two methyl groups and at the 19-position by one methyl group, or a salt thereof, is provided by the present invention. Such prostenoic acid derivatives have been found to exhibit such a therapeutic effectiveness that the amount of active substance administered to a patient can be reduced significantly in comparison with commercial preparations already available. |
| priorityDate |
1981-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |